New alternative approaches to stroke treatment: the blood cell–derived secretome shows promise in individuals with obesity
2025

New Approaches to Stroke Treatment for Obese Individuals

Sample size: 31 publication 10 minutes Evidence: moderate

Author Information

Author(s): Klaudia Kotorová, Jana Končeková, Martin Bona, Petra Bonová

Primary Institution: Biomedical Research Center of the Slovak Academy of Sciences, Institute of Neurobiology

Hypothesis

Can the blood cell-derived secretome improve stroke outcomes in obese animals?

Conclusion

The blood cell-derived secretome shows promise as a new treatment for individuals with obesity and ischaemic stroke, reducing infarct volume and neurodegeneration.

Supporting Evidence

  • A second round of RIPostC reduced neurodegeneration but did not significantly decrease infarct volume.
  • The blood cell-derived secretome significantly reduced infarct volume by approximately 30% compared to controls.
  • Neurological assessments showed significant improvement after treatment with the tolerant secretome.

Takeaway

Scientists found that a special treatment from healthy rats can help obese rats recover better after a stroke.

Methodology

The study involved two sub-studies using ZDF rats, one testing a second round of remote ischaemic postconditioning and the other administering a blood cell-derived secretome.

Potential Biases

Potential bias in animal selection and treatment administration.

Limitations

The study was conducted on animal models, which may not fully replicate human responses.

Participant Demographics

Male Zucker diabetic fatty (ZDF) rats aged 12 weeks.

Statistical Information

P-Value

p<0.0031

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s11011-024-01491-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication